Table 1 Age and gender distribution of the Aspergillus strains isolated from a clinical spectrum of aspergillosis
n (%) | Age range (y) | Gender (M:F) | |
|---|---|---|---|
No. of isolates | 114 | 6–90 | 2.0 |
Clinical diagnoses | |||
Extrapulmonary | 8 (7.0) | 20–60 | 1.6 |
IA proven | 8 (7.0) | 20–60 | 1.6 |
Pulmonary | 103 (90.4) | 6–90 | 2.0 |
IPA proven | 6 (5.3) | 11–60 | 2.0 |
IPA putative/probable | 11 (9.6) | 22–81 | 1.8 |
CPA | 58 (50.9) | 16–90 | 1.7 |
ABPA | 4 (3.5) | 6–32 | 1.0 |
SAFS | 4 (3.5) | 6.5–64 | 1.0 |
Saprophytic tracheobronchial aspergillosis | 23 (20.2) | 15–90 | 0.2 |
Previously triazole exposed isolates | 5 (4.4) | 40–65 | 0.7 |